门静脉期相对强化率与平扫CT鉴别乏脂性肾上腺肿瘤的诊断价值
本研究回顾性纳入2015年1月至2021年8月253例乏脂性肾上腺病变患者(121例乏脂性腺瘤,132例非腺瘤),评估门静脉期相对强化率鉴别乏脂性腺瘤与非腺瘤的诊断效能。相对强化率在95%特异度下鉴别乏脂性腺瘤与乏强化非腺瘤的敏感度高于平扫衰减(79% vs. 59%,p < 0.001),但鉴别乏脂性腺瘤与全部非腺瘤的敏感度与平扫衰减无显著差异(60% vs. 52%,p = 0.064),且鉴别乏脂性腺瘤与富强化非腺瘤的敏感度低于平扫衰减(26% vs. 69%,p < 0.001)。
要点
- 相对强化率鉴别乏脂性腺瘤与乏强化非腺瘤的敏感度(95%特异度下)为79%,高于平扫衰减的59%。
- 相对强化率鉴别乏脂性腺瘤与全部非腺瘤的敏感度为60%,与平扫衰减的52%无显著差异。
- 相对强化率鉴别乏脂性腺瘤与富强化非腺瘤的敏感度仅26%,低于平扫衰减的69%。
核心结论
- 相对强化率在鉴别乏脂性腺瘤与乏强化非腺瘤时诊断效能优于平扫衰减,但在鉴别乏脂性腺瘤与全部非腺瘤时诊断效能较差。
研究设计与样本
- 回顾性研究,连续纳入2015年1月至2021年8月共253例乏脂性肾上腺病变患者(平均年龄55 ± 12岁,男性135例),分为乏脂性腺瘤组(121例)和非腺瘤组(132例,含富强化与乏强化非腺瘤),采用Kruskal-Wallis检验、Bonferroni检验、ROC曲线分析及McNemar检验。
诊断标准与关键数值
- 在95%特异度下,相对强化率鉴别乏脂性腺瘤与全部非腺瘤的敏感度为60%,平扫衰减为52%(p = 0.064);鉴别乏脂性腺瘤与乏强化非腺瘤时相对强化率敏感度79%,平扫衰减59%(p < 0.001);鉴别乏脂性腺瘤与富强化非腺瘤时相对强化率敏感度26%,平扫衰减69%(p < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Adrenal incidentalomas are common lesions found on abdominal imaging, most of which are lipid-rich adrenal adenomas. Imaging diagnoses differentiating lipid-poor adrenal adenomas (LPA) from non-adenomas (NA) are presently challenging to perform. The aim of the study was to investigate the diagnostic performance of the relative enhancement ratio parameter in identifying LPA from NA.
METHODS: We retrospectively evaluated consecutively presenting patients with lipid-poor adrenal lesions (January 2015 to August 2021). Lesions were divided into LPA and NA (including hyperenhancing and hypoenhancing NA). Kruskal-Wallis and Bonferroni tests were used to determine the differences in feature parameters between these three groups. Receiver operating characteristic curve analysis was performed to determine the sensitivity for diagnosing LPA and NA at 95% specificity; the parameters were compared using the McNemar test.
RESULTS: A total of 253 patients (mean age, 55 ± 12 years; 135 men), 121 with LPA and 132 with NA, were analyzed herein. The sensitivity (achieved at 95% specificity) of the relative enhancement ratio was higher than that of unenhanced attenuation in differentiating LPA from NA (60% vs. 52%, p = 0.064). The relative enhancement ratio yielded a higher sensitivity than unenhanced attenuation (79% vs. 59%, p < 0.001) in differentiating LPA from hypoenhancing NA, and a lower sensitivity (26% vs. 69%, p < 0.001) in differentiating LPA from hyperenhancing NA.
CONCLUSION: The relative enhancement ratio showed better diagnostic performance than unenhanced attenuation in differentiating LPA from hypoenhancing NA, while simultaneously showing poor diagnostic performance in identifying LPA from all NA.
引用
- Jin, Zhang, Pan, et al. Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors. Abdom Radiol (NY). 2022. PMID: 35778569. doi:10.1007/s00261-022-03593-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。